Seaport Therapeutics, Inc. Ttl Offset Amt
Seaport Therapeutics, Inc. (SPTX) had Ttl Offset Amt of $0 as of 2026-05-01, per its S-8 filed 2026-05-04.
Financial Statements › Notes
ffd:TtlOffsetAmt · last filed 2026-05-04
- 2026-05-01: Ttl Offset Amt $0.00.
- 2026-04-30: Ttl Offset Amt $0.00.
- 2026-04-23: Ttl Offset Amt $0.00.
- 2026-04-07: Ttl Offset Amt $0.00.
| Period end | Ttl Offset Amt |
|---|---|
| 2026-05-01 | $0.00 S-8 · filed 2026-05-04 |
| 2026-04-30 | $0.00 S-1MEF · filed 2026-04-30 |
| 2026-04-23 | $0.00 S-1/A · filed 2026-04-27 |
| 2026-04-07 | $0.00 S-1 · filed 2026-04-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |